Ionis Pharmaceuticals (IONS) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $161.1 million.
- Ionis Pharmaceuticals' Shares Outstanding rose 210.69% to $161.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.1 million, marking a year-over-year increase of 210.69%. This contributed to the annual value of $157.9 million for FY2024, which is 940.0% up from last year.
- Ionis Pharmaceuticals' Shares Outstanding amounted to $161.1 million in Q3 2025, which was up 210.69% from $159.2 million recorded in Q2 2025.
- Ionis Pharmaceuticals' Shares Outstanding's 5-year high stood at $161.1 million during Q3 2025, with a 5-year trough of $140.9 million in Q1 2021.
- For the 5-year period, Ionis Pharmaceuticals' Shares Outstanding averaged around $147.0 million, with its median value being $143.2 million (2023).
- In the last 5 years, Ionis Pharmaceuticals' Shares Outstanding surged by 57.37% in 2022 and then skyrocketed by 1005.63% in 2024.
- Ionis Pharmaceuticals' Shares Outstanding (Quarter) stood at $141.2 million in 2021, then rose by 0.6% to $142.1 million in 2022, then increased by 1.61% to $144.3 million in 2023, then increased by 9.4% to $157.9 million in 2024, then increased by 2.04% to $161.1 million in 2025.
- Its last three reported values are $161.1 million in Q3 2025, $159.2 million for Q2 2025, and $159.0 million during Q1 2025.